Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2021 Jun 5;61(1):46–55. doi: 10.1016/j.jaac.2021.03.011

Table 3.

CDRS-R Composite and QIDS Total Composite Response and Remission by Treatment Group

n Total TAU GENE p-value

QIDS response 8 week 155 56 (36.1%) 27 (34.6%) 29 (37.7%) 0.693
6 month 125 66 (52.8%) 36 (56.3%) 30 (49.2%) 0.429

QIDS remission 8 week 155 20 (12.9%) 8 (10.3%) 12 (15.6%) 0.323
6 month 125 30 (24.0%) 15 (23.4%) 15 (24.6%) 0.880

CDRS-R response 8 week 155 110 (71.0%) 56 (71.8%) 54 (70.1%) 0.819
6 month 125 100 (80.0%) 55 (86.9%) 45 (73.8%) 0.089

CDRS-R remission 8 week 155 50 (32.3%) 22 (28.2%) 28 (36.4%) 0.277
6 month 125 69 (47.2%) 29 (46.9%) 29 (47.5%) 0.941

Note: CDRS-R = Children’s Depression Rating Scale, Revised; GENE = Pharmacogenetics Guided Treatment; QIDS = Quick Inventory of Depressive Symptomatology; TAU = Treatment As Usual